Introduction: The Italian Medicines Agency indicates that about 5% of hospital admissions are due to adverse drug reactions (ADRs). Several factors are recognized to be associated with an increased risk for ADRs, such as the female gender and polytherapy. The aim of this study was to retrospectively analyze the suspected ADRs reported by patients during the anamnestic interview at the Allergy Unit. Patients and Methods: ALLERG-RAF study is a retrospective analysis of the medical records of patients evaluated in the Allergy Unit of ASST Spedali Civili and the University of Brescia from 2000 to 2016. The inclusion criteria were age ≥18 years and medical consultation requested for suspected ADRs. Data relating to the patient’s intrinsic characteristics, the drug supposed to be the cause, and the prescribed pharmacological therapy were collected. Pseudonymized data from each patient were collected in an informatics database. Results: From 2000 to 2016, 35,817 accesses to the Allergy Unit were made, and 2,171 unique events related to a suspected ADR were collected in 1,840 patients. More than two-thirds of the reports concerned females (70.4%). Antibiotics were involved in the majority of the self-reported suspected ADRs (48.7%), particularly beta-lactams (61.1%). Anti-inflammatory drugs, mainly NSAIDs, were second in incidence and suspected in 25.2% of reports. As a site of ADR manifestation, most of the reported reactions involve the skin. No clinical sequelae were reported. Conclusions: Our results underline the importance of patient reporting in pharmacovigilance. Furthermore, gender gap data emphasizes the importance of the gender-specific medicine approach.

1.
WHO: World Health Organization
.
International drug monitoring: role of national centers. Technical Report Series No. 498
.
Geneva
:
World Health Organization
;
1972
:
Vols. 1–25
.
2.
Directive 2010/84/EU of the European parliament and of the council
. In:
Official journal of the European union
.
Vol. 31, 12
.
2010
. Available from: https://eur-lex.europa.eu/legal-content/IT/ALL/?uri=CELEX:32010L0084 (accessed May 29, 2023).
3.
Rawlins
MD
,
Thompson
JW
.
Pathogenesis of adverse drug reaction
. In:
Davies
DM
, editor.
Textbook of adverse drug reaction
.
Oxford
:
Oxford University Press
;
1977
. p.
10
.
4.
Edwards
IR
,
Aronson
JK
.
Adverse drug reactions: definitions, diagnosis, and management
.
Lancet
.
2000
;
356
(
9237
):
1255
9
. doi: .
5.
Aronson
JK
,
Ferner
RE
.
Joining the DoTS: new approach to classifying adverse drug reactions
.
BMJ
.
2003
;
327
(
7425
):
1222
5
. doi: .
6.
Sultana
J
,
Cutroneo
P
,
Trifirò
G
.
Clinical and economic burden of adverse drug reactions
.
J Pharmacol Pharmacother
.
2013
;
4
(
Suppl 1
):
S73
7
. doi: .
7.
Bouvy
JC
,
De Bruin
ML
,
Koopmanschap
MA
.
Epidemiology of adverse drug reactions in Europe: a review of recent observational studies
.
Drug Saf
.
2015
;
38
(
5
):
437
53
. doi: .
8.
Farmacovigilanza
.
Agenzia Italiana del Farmaco web site | L’Agenzia | Normativa
. https://www.aifa.gov.it/normativa-di-riferimento-farmacovigilanza (accessed November 29, 2023).
9.
Cacabelos
R
,
Naidoo
V
,
Corzo
L
,
Cacabelos
N
,
Carril
JC
.
Genophenotypic factors and pharmacogenomics in adverse drug reactions
.
Int J Mol Sci
.
2021
;
22
(
24
):
13302
Published 2021 Dec 10. doi: .
10.
Rademaker
M
.
Do women have more adverse drug reactions
.
Am J Clin Dermatol
.
2001
;
2
(
6
):
349
51
. doi: .
11.
Soldin
OP
,
Mattison
DR
.
Sex differences in pharmacokinetics and pharmacodynamics
.
Clin Pharmacokinet
.
2009
;
48
(
3
):
143
57
. doi: .
12.
Zucker
I
,
Prendergast
BJ
.
Sex differences in pharmacokinetics predict adverse drug reactions in women
.
Biol Sex Differ
.
2020
;
11
(
1
):
32
Published 2020 Jun 5. doi: .
13.
Study and evaluation of gender differences in the clinical evaluation of drugs
. In:
Guidance for industry
.
1993
. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/study-and-evaluation-gender-differences-clinical-evaluation-drugs (accessed May 29, 2023).
14.
ICH Gender considerations in the conduct of clinical trials
. In:
EMA website. 05.01
.
2005
Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-gender-considerations-conduct-clinical-trials-step-5_en.pdf (accessed May 29, 2023).
15.
Magro
L
,
Arzenton
E
,
Leone
R
,
Stano
MG
,
Vezzaro
M
,
Rudolph
A
, et al
.
Identifying and characterizing serious adverse drug reactions associated with drug-drug interactions in a spontaneous reporting database
.
Front Pharmacol
.
2020
;
11
:
622862
Published 2021 Jan 18. doi: .
16.
Come segnalare una reazione avversa
. In:
Agenzia Italiana del Farmaco website | Sicurezza dei Farmaci
. Available from: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse (accessed May 29, 2023).
17.
Inácio
P
,
Cavaco
A
,
Airaksinen
M
.
The value of patient reporting to the pharmacovigilance system: a systematic review
.
Br J Clin Pharmacol
.
2017
;
83
(
2
):
227
46
. doi: .
18.
Eudravigilance. Available from: https://www.adrreports.eu/it/eudravigilance.html (accessed on 20 October 2023).
19.
Conforti
A
,
Opri
S
,
D’Incau
P
,
Sottosanti
L
,
Moretti
U
,
Ferrazin
F
, et al
.
Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database
.
Pharmacoepidemiol Drug Saf
.
2012
;
21
(
6
):
597
602
. doi: .
20.
Vardakas
KZ
,
Kalimeris
GD
,
Triarides
NA
,
Falagas
ME
.
An update on adverse drug reactions related to β-lactam antibiotics
.
Expert Opin Drug Saf
.
2018
;
17
(
5
):
499
508
. .
21.
Sturkenboom
MC
,
Verhamme
KM
,
Nicolosi
A
,
Murray
ML
,
Neubert
A
,
Caudri
D
, et al
.
Drug use in children: cohort study in three European countries
.
BMJ
.
2008
;
337
:
a2245
Published 2008 Nov 24. doi: .
22.
Barbieri
E
,
di Chiara
C
,
Costenaro
P
,
Cantarutti
A
,
Giaquinto
C
,
Hsia
Y
, et al
.
Antibiotic prescribing patterns in paediatric primary care in Italy: findings from 2012-2018
.
Antibiot
.
2021
;
11
(
1
):
18
. doi: .
23.
Jiang
H
,
Lin
Y
,
Ren
W
,
Fang
Z
,
Liu
Y
,
Tan
X
, et al
.
Adverse drug reactions and correlations with drug-drug interactions: a retrospective study of reports from 2011 to 2020
.
Front Pharmacol
.
2022
;
13
:
923939
. doi: .
24.
de Vries
ST
,
Denig
P
,
Ekhart
C
,
Burgers
JS
,
Kleefstra
N
,
Mol
PGM
, et al
.
Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in The Netherlands: an explorative observational study
.
Br J Clin Pharmacol
.
2019
;
85
(
7
):
1507
15
. doi: .
25.
Fernández-Liz
E
,
Modamio
P
,
Catalán
A
,
Lastra
CF
,
Rodríguez
T
,
Mariño
EL
.
Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain
.
Br J Clin Pharmacol
.
2008
;
65
(
3
):
407
17
Epub 2007 Oct 8. doi: .
26.
Anthony
M
,
Lee
KY
,
Bertram
CT
,
Abarca
J
,
Rehfeld
RA
,
Malone
DC
, et al
.
Gender and age differences in medications dispensed from a national chain drugstore
.
J Womens Health
.
2008
;
17
(
5
):
735
43
. doi: .
27.
Orlando
V
,
Mucherino
S
,
Guarino
I
,
Guerriero
F
,
Trama
U
,
Menditto
E
.
Gender differences in medication use: a drug utilization study based on real World data
.
Int J Environ Res Public Health
.
2020
;
17
(
11
):
3926
. doi: .
28.
Biagi
C
,
Montanaro
N
,
Buccellato
E
,
Roberto
G
,
Vaccheri
A
,
Motola
D
.
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region)
.
Eur J Clin Pharmacol
.
2013
;
69
(
2
):
237
44
Epub 2012 Jun 17. doi: .
29.
Durrieu
G
,
Jacquot
J
,
Mège
M
,
Bondon-Guitton
E
,
Rousseau
V
,
Montastruc
F
, et al
.
Completeness of spontaneous adverse drug reaction reports sent by general practitioners to a regional pharmacovigilance centre: a descriptive study
.
Drug Saf
.
2016
;
39
(
12
):
1189
95
. doi: .
30.
Li
R
,
Curtis
K
,
Van
C
,
Tabish Razi Zaidi
S
,
Yeo
CY
,
Arun Kali
C
, et al
.
Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
.
Eur J Clin Pharmacol
.
2022
;
78
(
7
):
1165
75
. Epub 2022 Apr 27. doi: .
31.
Caughey
GE
,
Tait
K
,
Vitry
AI
,
Shakib
S
.
Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity
.
Patient Prefer Adherence
.
2017
;
11
:
131
40
. doi: .
32.
Lim
R
,
Ellett
LK
,
Roughead
EE
,
Cheah
PY
,
Masnoon
N
.
Patient-reported questionnaires to identify adverse drug reactions: a systematic review
.
Int J Environ Res Public Health
.
2021
;
18
(
22
):
11877
Erratum in: Int J Environ Res Public Health. 2022 Sep 07;19(18). doi: .
You do not currently have access to this content.